get a key
steadybase-$ company SPRO
account_id none on file
legal_name Spero Therapeutics, Inc.
ticker SPRO
cik 1701108
domain sperotherapeutics.com
entry_point_account_id none on file
name Spero Therapeutics Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 0 executives 6 family 0
why_nownone on file
callsnone on file
filingsnone on file
executives
Cynthia Smith director - receipt
Esther Rajavelu Chief Financial Officer - receipt
Satyavrat Shukla Chief Financial Officer - receipt
Scott Jackson director - receipt
Stephen J. DiPalma Interim Chief Financial Officer - receipt
Timothy Keutzer Chief Operating Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2023-11-01 Chief Financial Officer, appointed sec_8k
2023-06-14 Interim Chief Financial Officer, appointed sec_8k
2023-02-01 Chief Operating Officer, appointed sec_8k
2020-12-17 Chief Financial Officer, appointed sec_8k
2020-05-11 director, appointed sec_8k
2019-03-29 director, appointed sec_8k
mcp_package_hint
steadybase-$